Q-line Biotech Ltd 52 Week High
Q-Line Biotech Ltd
NSE: Q-LineBiotech
YEARHIGH
Key Highlights
- The 52 Week HIGH of Q-Line Biotech Ltd is ₹ 735 as of 30 Sep 26 .
Company Fundamentals for Q-Line Biotech Ltd
Market Price of Q-Line Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Sep 2026 | 681 |
| 29 Sep 2026 | 672.75 |
| 28 Sep 2026 | 666.7 |
| 25 Sep 2026 | 668.45 |
| 24 Sep 2026 | 674.85 |
| 23 Sep 2026 | 699.55 |
| 22 Sep 2026 | 683.25 |
| 21 Sep 2026 | 698.2 |
| 18 Sep 2026 | 696.95 |
| 17 Sep 2026 | 722.1 |
Asset Value vs Market Value of Q-Line Biotech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Q-Line Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Q-Line Biotech Ltd
Historical Net Profit of Q-Line Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Q-Line Biotech Ltd
Q-Line Biotech Ltd News Hub
Q-Line Biotech to hold board meeting
Q-Line Biotech will hold a meeting of the Board of Directors of the Company on 5 September 2026.
Read more
05 Sept 26
NSE SME Q-Line Biotech lands on Dalal Street with a strong pulse
The scrip was listed at Rs 452, a 31.78% premium to the initial public offer (IPO) price. The stock
Read more
29 May 26
Q-Line Biotech schedules AGM
Q-Line Biotech announced that the 16th Annual General Meeting(AGM) of the company will be held on 30
Read more
10 Sept 26
